TeenaBhatlaMD
Pediatric Hematology & Oncology • New York, NYPediatric Anemia and Red Blood Cell Hematology, Pediatric Hematologic Oncology, Pediatric Solid Tumor Oncology
Director, The Valerie Fund Children's Center for Cancer and blood disorder, Division of Pediatric Hematology-oncology, Department of Pediatrics, Children's Hospital of New Jersey at Newark Beth Israel Medical Center
Dr. Bhatla is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
550 1st Ave
New York, NY 10016
Summary
- Dr. Teena Bhatla is a pediatric hematologist/oncologist in Newark, NJ and is affiliated with multiple hospitals in the area, including Newark Beth Israel Medical Center, Newark Beth Israel Medical Center, and Saint Barnabas Medical Center. She received her medical degree from Sawai Man Singh Medical College and has been in practice 16 years. She specializes in pediatric anemia and red blood cell hematology, pediatric hematologic oncology, and pediatric solid tumor oncology and is experienced in pediatric hematology and oncology and pediatric red blood cell hematology.
Education & Training
NYU Grossman School of MedicineFellowship, Pediatric Hematology/Oncology, 2008 - 2011
Maimonides Medical Center/Infants and Children's Hospital of BrooklynResidency, Pediatrics, 2006 - 2008
Sawai Man Singh Medical CollegeClass of 2001
Certifications & Licensure
NJ State Medical License 2018 - 2025
NY State Medical License 2013 - 2018
MI State Medical License 2008 - 2009- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia Start of enrollment: 2019 Jul 03
Publications & Presentations
PubMed
- Larotrectinib for Newly Diagnosed Infantile Fibrosarcoma and Other PediatricFusion-Positive Solid Tumors (Children's Oncology Group ADVL1823).Theodore W Laetsch, Stephan Voss, Kathleen Ludwig, David Hall, Donald A Barkauskas
Journal of Clinical Oncology. 2024-12-09 - 1 citationsDaratumumab in pediatric relapsed/refractory acute lymphoblastic leukemia or lymphoblastic lymphoma: the DELPHINUS study.Teena Bhatla, Laura E Hogan, David T Teachey, Francisco Bautista, John Moppett
Blood. 2024-11-21 - Low-risk relapsed acute lymphoblastic leukemia in children and young adults: what have we learnt and what's next?Teena Bhatla, Stacy Cooper, Laura E Hogan
Leukemia & Lymphoma. 2024-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
